Umb Bank, N.A. Seagen Inc. Transaction History

Umb Bank, N.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 18, 2023	SELL	$191.51 - $216.16 $4,787 - $5,404	-25 Reduced 65.79%	13 $2,000
Q2 2023 Jul 25, 2023	BUY	$187.64 - $206.25 $187 - $206	1 Added 2.7%	38 $7,000
Q4 2022 Jan 10, 2023	BUY	$117.37 - $139.17 $821 - $974	7 Added 23.33%	37 $5,000
Q3 2022 Oct 13, 2022	SELL	$135.27 - $180.11 $5,275 - $7,024	-39 Reduced 56.52%	30 $4,000
Q4 2021 Feb 09, 2022	BUY	$142.57 - $190.86 $9,837 - $13,169	69 New	69 $11,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

Stay updated on Umb Bank, N.A. with notifications on news.